Matterworks, Inc.

About Matterworks, Inc.

Matterworks, Inc. empowers life sciences R&D by transforming biological research from empirical to predictive through its AI-driven platform, Pyxis. Leveraging a Large Spectral Model trained on billions of spectra, Matterworks makes biochemical omics broadly accessible, uncovering hidden predictive power in complex datasets. Their solutions serve biopharmaceutical companies, enabling asset and target discovery, derisking toxicology and safety assessments, predicting clinical outcomes, and optimizing biomanufacturing processes. This innovative approach aims to significantly improve the success rate of life science pipeline R&D by providing deeper biological insights and predictive capabilities, helping to build the future of predictive biology.